scholarly journals Pneumococcal vaccination in general practice

2015 ◽  
Vol 156 (5) ◽  
pp. 186-191
Author(s):  
Péter Vajer ◽  
Ferenc Tamás ◽  
Róbert Urbán ◽  
Péter Torzsa ◽  
László Kalabay
Keyword(s):  
General Practitioners ◽  
Pneumococcal Disease ◽  
Pneumococcal Vaccination ◽  
Daily Practice ◽  
Developed Countries ◽  
Vaccination Rate ◽  
Prescription Rate ◽  
Routine Method ◽  
Vaccination Rates ◽  
The Mean

Introduction: The prevalence of invasive pneumococcal disease, which is depending on risk factors and comorbidities, is increasing over the age of 50 years. Most developed countries have recommendations but vaccination rates remain low. Aim: To assess the general practitioners’ daily practice in relation to pneumococcal vaccination and analyse the effect of informing the subjects about the importance of pneumococcal vaccination on vaccination routine. Method: Subjects over 50 years of age vaccinated against influenza during the 2012/2013 campaign were informed about the importance of pneumococcal vaccination and asked to fill in a questionnaire. Results: Of the 4000 subjects, 576 asked for a prescription of pneumococcal vaccine (16.5% of females and 11.6% of males, OR 1.67 CI 95% 1.37–2.04, p<0.001) and 310 were vaccinated. The mean age of females and males was 70.95 and 69.8 years, respectively (OR 1.01; CI 95% 1.00–1.02; p<0.05). Information given by physicians resulted in 33,6% prescription rate, while in case it was 8% when nurses provided information (OR 6.33; CI 95% 5.23–7.67; p<0.001). As an effect of this study the vaccination rate was 6.3 times higher than in the previous year campaign (p<0.001). Conclusions: General practitioners are more effective in informing subjects about the importance of vaccination than nurses. Campaign can raise the vaccination rate significantly. Orv. Hetil., 2015, 156(5), 186–191.

Improving pneumococcal vaccination rates in pediatric acute lymphoblastic leukemia/lymphoblastic lymphoma.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e18666-e18666
Author(s):  
Simone Chang ◽  
Alexandra Cheerva ◽  
Michael Angelo Huang ◽  
Kerry McGowan ◽  
Esther E Knapp ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
Hematologic Malignancy ◽  
Lymphoblastic Leukemia ◽  
Pneumococcal Vaccination ◽  
Vaccination Rate ◽  
Lymphoblastic Lymphoma ◽  
Pediatric Acute Lymphoblastic Leukemia ◽  
Vaccination Rates ◽  
Targeted Interventions ◽  
Pediatric All

e18666 Background: Pediatric Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (ALL/LLy) is the most common pediatric cancer. Invasive pneumococcal disease (IPD) is prevalent in this population and the Centers for Disease Control and Prevention recommends pneumococcal vaccination to decrease morbidity and mortality. Despite these recommendations, vaccination rates remain low and the incidence of IPD among children with hematologic malignancy is significantly higher compared to the average pediatric population. An interventional study was designed to improve the vaccination rate and reduce the incidence of IPD in our institution. Methods: A plan-do-study-act (PDSA) model of quality improvement (QI) was used. Chart review at our institute was done for the 6-month period of January 2020 - June 2020 and baseline rates for pneumococcal polysaccharide (PPSV23) vaccination were calculated. Patients were included if they were ≥ 2 years old, diagnosed with ALL/LLy, and undergoing maintenance. A multidisciplinary team performed the root cause analysis. Immunization records were obtained and reviewed and targeted interventions were implemented. The interventions used are outlined in Table. The percentage of pediatric ALL/LLy patients per month in maintenance who received age-appropriate pneumococcal vaccinations was monitored before and after the interventions. Results: Analysis of the 6-month retrospective cohort (n=36) showed a baseline vaccination rate of 5.5%. During the subsequent 6-month phase with interventions, 40 patients were prospectively enrolled. Demographics showed a mean age of 10.2 years (range, 2-21) and a predominantly male (66.7%) cohort. B-cell ALL/LLy comprised the majority (78.9%); the rest included T-cell ALL/LLy and mixed phenotype acute leukemia. As seen in Table, the percentage receiving at least 1 pneumococcal vaccine increased from 5.5% to 84.8% over the first 3 months, this plateaued around 81%. Completion of the series mirrored this and increased to 74.2%. Pre-visit planning and cues proved to be the most helpful interventions. Conclusions: Use of a PDSA model successfully improved pneumococcal vaccination rates in the pediatric ALL/LLy population. We suggest these results can be achieved with planning and implementation of the outlined interventions. [Table: see text]

scholarly journals Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection

2002 ◽  
Vol 129 (3) ◽  
pp. 515-524 ◽  
Author(s):  
B. CHRISTENSON ◽  
P. LUNDBERGH
Keyword(s):  
Influenza Vaccination ◽  
Chronic Diseases ◽  
Demographic Data ◽  
Pneumococcal Infection ◽  
Pneumococcal Vaccination ◽  
Vaccination Rate ◽  
Elderly Persons ◽  
Vaccination Rates ◽  
Myocardial Disease ◽  
Chronic Lung Diseases

This study characterizes possible confounders that might make cohorts vaccinated and unvaccinated against influenza and pneumococcal infection different at baseline, with the hypothesis that the two cohorts are comparable. The similarity between health and demographic data was analysed by a randomized, multivariant study addressed to 10 000 persons aged 65 years and older in Stockholm County and was carried out in the form of a postal inquiry during the period December 2000 to May 2001. The study-population response rate was 78%. Of these, 66% (5120 persons) had been given at least one influenza vaccination during the 3-year study period (1998–2000), 50% (3780) had received one pneumococcal vaccination and 78% had received both vaccines during the period. The vaccination rate was lower in the age group 65–69 years (60%), compared with elderly cohorts aged over 70 years (67–72%, P<0·001). Elderly persons living in nursing homes or institutions had higher vaccination rates than persons living in their own households (72 vs. 67%). Persons with underlying chronic diseases had higher vaccination rates (71%, P<0·001) than those without underlying chronic diseases. Vaccine recipients had fewer days in hospital, compared with non-recipients. Unvaccinated persons with myocardial disease had nine times more days in hospital than vaccinated persons with myocardial disease. Vaccination against pneumococcal infection had an additional effect with influenza vaccination in reducing hospitalization for chronic lung diseases; influenza vaccination alone did not have this effect. In conclusion, the influenza and pneumococcal-vaccine recipients were older and had significantly more chronic lung and heart conditions than the unvaccinated cohort.

scholarly journals A Multifaceted Intervention to Improve Influenza, Pneumococcal, and Herpes Zoster Vaccination among Patients with Rheumatoid Arthritis

2016 ◽  
Vol 43 (6) ◽  
pp. 1030-1037 ◽  
Author(s):  
David W. Baker ◽  
Tiffany Brown ◽  
Ji Young Lee ◽  
Amanda Ozanich ◽  
David T. Liss ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Insurance Coverage ◽  
Pneumococcal Vaccination ◽  
Vaccination Rate ◽  
Rate Of Change ◽  
System Level ◽  
Vaccination Rates ◽  
Order Sets ◽  
Vaccination History ◽  
Patient Outreach

Objective.Vaccination rates for influenza, pneumococcus, and zoster in patients with rheumatoid arthritis (RA) have remained low. Simple electronic or paper reminders have produced only small increases in vaccination rates. We sought to identify a more effective approach to improve vaccination rates.Methods.We conducted a system-level intervention at an academic rheumatology clinic that included electronic reminders with linked order sets, physician auditing and feedback, patient outreach, and optional printed prescriptions for zoster vaccination at an outside pharmacy.Results.We targeted 1255 eligible patients with RA. There was no change in patients’ self-reported influenza vaccination rates, although the baseline self-reported rate was already high and much higher than that documented in the electronic health record. Pneumococcal vaccination rates increased from 28.7% to 45.8%; in regression analysis, the rate of change in pneumococcal vaccination increased by 9.4% per year above baseline trends (95% CI 3.9–15.5, p = 0.002). The rate of zoster vaccination increased from 2.5% to 4.5% overall (p = 0.01) and from 3.0% to 6.6% among patients not receiving biologic therapy that precluded zoster vaccination.Conclusion.Although the intervention improved pneumococcal and zoster vaccination rates, the improvement in pneumococcal vaccination rate was less than expected, and the zoster vaccination rate remained low even for ideal candidates. Likely barriers include lack of familiarity and difficulty using electronic reminders and order sets, uncertainty about the value and safety of recommended vaccines, and uncertainty about patients’ insurance coverage and prior vaccination history. Future interventions should include strategies to address these.

Increasing Pneumococcal Vaccination Rates Among Residents of Long-Term–Care Facilities: Provider-Based Improvement Strategies Implemented by Peer-Review Organizations in Four Western States

2000 ◽  
Vol 21 (11) ◽  
pp. 705-710 ◽  
Author(s):  
Kurt B. Stevenson ◽  
John W. McMahon ◽  
Jan Harris ◽  
J. Richard Hillman ◽  
Steven D. Helgerson
Keyword(s):  
Long Term Care ◽  
Pneumococcal Vaccination ◽  
Vaccination Rate ◽  
Term Care ◽  
Improvement Project ◽  
Vaccination Rates ◽  
Standing Order ◽  
Care Facilities ◽  
Collaborative Efforts

AbstractObjective:To evaluate collaborative efforts and intervention strategies by peer-review organizations (PROs) and long-term-care facilities (LTCFs) for improving pneumococcal vaccination rates among residents of LTCFs.Design:Prospective, before-after quality improvement project.Setting:133 LTCFs in Alaska, Idaho, Montana, and Wyoming.Patients:All residents of participating LTCFs.Methods:Baseline pneumococcal vaccination rates were determined by medical-record review, self-reporting by patient or family members, and review of Medicare claims information. Remeasurement of vaccination rates was accomplished from documentation of vaccination of eligible residents by each LTCF.Results:133 LTCFs with 7,623 residents from Alaska, Idaho, Montana, and Wyoming participated in this quality-improvement project. This accounted for 41% (133/321) of the potential nursing homes and resident population in the participating states. Baseline overall vaccination rates were 40% (3,050/7,589). The overall vaccination rate improved to 75% (5,720/7,623, P<.001). The number of facilities meeting the Healthy People 2000 vaccination goal of 80% improved from 18% (24/133) to 62% (83/133, P<.001). Initial use of chart stickers and implementation of standing orders led to similar increases in vaccination rates, but the standing-order strategy required commitment of fewer PRO resources at a statewide level. Remeasurement of vaccination rates in a subset of participating Idaho LTCFs 1 year after initial vaccination efforts demonstrated a sustained vaccination rate of 70% in facilities enforcing a standing-order policy.Conclusions:Simple and straightforward vaccination strategies implemented in LTCFs over a short period of time can have a significant impact on vaccination rates. Collaborative efforts between state PROs and LTCFs enhance implementation of these strategies and can result in the achievement of national vaccination objectives. Standing orders appear to be one intervention effective in sustaining successful vaccination efforts. Regardless of the specific interventions employed, PROs played a significant role in facilitating vaccination program development and intervention implementation.

scholarly journals Shared Decision Making Enhances Pneumococcal Vaccination Rates in Adult Patients in Outpatient Care

2020 ◽  
Vol 17 (23) ◽  
pp. 9146
Author(s):  
Flora Kuehne ◽  
Linda Sanftenberg ◽  
Tobias Dreischulte ◽  
Jochen Gensichen
Keyword(s):  
Health Care ◽  
Decision Making ◽  
Shared Decision Making ◽  
Pneumococcal Disease ◽  
Patient Activation ◽  
Pneumococcal Vaccination ◽  
Adult Patients ◽  
Shared Decision ◽  
Vaccination Rates ◽  
Exchange Of Information

Insufficient vaccination rates against pneumococcal disease are a major problem in primary health care, especially in adult patients. Shared decision-making (SDM) may address major barriers to vaccination. The objective of this review was to assess the impact of SDM on pneumococcal vaccination rates in adult patients. We conducted a systematic literature search in MEDLINE, EMBASE, CENTRAL, PsycINFO, and ERIC. RCTs and cluster RCTs were included, if they aimed to enhance pneumococcal vaccination rates in adult patients and comprised a personal interaction between health care provider (HCP) and patient. Three further aspects of the SDM process (patient activation, bi-directional exchange of information and bi-directional deliberation) were assessed. A meta-analysis was conducted for the effects of interventions on vaccination rates. We identified eight studies meeting the inclusion criteria. The pooled effect size was OR (95% CI): 2.26 (1.60–3.18) comparing intervention and control groups. Our findings demonstrate the efficacy of interventions that enable a SDM process to enhance pneumococcal vaccination rates; although, the quality of evidence was low. In exploratory subgroup analyses, we concluded that an impersonal patient activation and an exchange of information facilitated by nurses are sufficient to increase vaccination rates against pneumococcal disease in adult patients. However, the deliberation of options between physicians and patients seemed to be more effective than deliberation of options between nurses and patients.

scholarly journals An observational study on pneumococcal and influenza vaccination status of patients with type 2 diabetes mellitus

2018 ◽  
Vol 6 (12) ◽  
pp. 3842
Author(s):  
Rafiq A. Bhat ◽  
Saleem A. Wani ◽  
Rajat Kharbanda ◽  
Sumit Sethi
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pneumococcal Disease ◽  
Pneumococcal Vaccination ◽  
Vaccination Rates ◽  
Vaccination Uptake ◽  
Increased Risk ◽  
Patients With Diabetes

Background: India has more than sixty million subjects with diabetes. Diabetes confers an increased risk of developing and dying from infectious diseases with an enhanced susceptibility to morbidity, mortality and hospitalizations due to influenza and pneumococcal disease. The Advisory Committee on Immunization Practices (ACIP) recommends influenza and pneumococcal vaccines for all individuals with diabetes.Methods: Around 249 patients with type 2 diabetes mellitus were enrolled in the study. All patients were asked a detailed history about diabetes, its duration, type of diabetes and the vaccinations for influenza and pneumococcus, who suggested vaccination and the reasons for declining the vaccination if it had been medically advised. Any other co-morbid condition such as hypertension, diabetes mellitus, heart disease, COPD, hypothyroidism and CKD were noted.Results: Vaccination rates for influenza in patients aged 50 or more were higher (7.6% of 172 patients) as compared to those aged <50 years (0% of 77); (p=0.013) whereas pneumococcal vaccination rates were 8.1% as against 1.3% (p=0.036) respectively. In males the vaccination rates for influenza were 4.7% compared to females (5.8%); (p=0.675), whereas for pneumococcus the respective vaccination rates were 6.2% for male and 5.8% for female (p=0.903). Vaccination uptake among male and female were almost same. Patients having chronic kidney disease on dialysis were having highest vaccination rate.Conclusions: The poor vaccination uptake for influenza and pneumococcus in patients with diabetes, calls for intensive efforts aimed at increasing coverage.

Overcoming Barriers to Establishing an Inpatient Vaccination Program for Pneumococcus Using Standing Orders

2005 ◽  
Vol 26 (11) ◽  
pp. 874-881 ◽  
Author(s):  
Donald B. Middleton ◽  
Dwight E. Fox ◽  
Mary Patricia Nowalk ◽  
Susan J. Skledar ◽  
Denise R. Sokos ◽  
...  
Keyword(s):  
Medical Center ◽  
Tertiary Care ◽  
Pneumococcal Vaccination ◽  
Vaccination Rate ◽  
Vaccination Program ◽  
Successful Implementation ◽  
Close Monitoring ◽  
University Of Pittsburgh ◽  
Vaccination Rates ◽  
The University

AbstractObjectives:To identify and classify barriers to establishing a standing orders program (SOP) for adult pneumococcal vaccination in acute care inpatient facilities and to provide recommendations for overcoming these roadblocks. Vaccination rates in hospitals with SOPs are generally higher than those in hospitals that require individual physician orders. The array of solutions drawn from our experience in different hospital settings should permit many types of facilities to anticipate and overcome barriers, allowing a smoother transition from initiation to successful implementation of an inpatient pneumococcal vaccination SOP.Design:Descriptive study of barriers and solutions encountered during implementation of a pneumococcal vaccination SOP in three hospitals of the University of Pittsburgh Medical Center Health System (UPMC) and in the scientific literature.Setting:As of 2004, two UPMC tertiary-care hospitals and one UPMC community hospital had incorporated SOPs into existing physician order-driven programs for inpatient vaccination with pneumococcal polysaccharide vaccine.Results:Barriers were identified at each step of implementation and categorized as patient related, provider related, or institutional. Based on a process of continual review and revision of our programs in response to encountered barriers, steps were taken to overcome these impediments.Conclusions:A strong commitment by key individuals in the facility's administration including a physician champion; ongoing, persistent efforts to educate and train staff; and close monitoring of the vaccination rate were essential for successful implementation of a SOP for pneumococcal vaccination of eligible inpatients. Legal statutes and evaluations of external hospital-rating associations regarding the effectiveness of the vaccination program were major motivating factors in its success.

scholarly journals Weak or No Correlation Between Recent COVID-19 Data and Vaccination Rates in France

2021 ◽  
Author(s):  
Mohamed Bouanane
Keyword(s):  
Healthcare Services ◽  
Developed Countries ◽  
Vaccination Rate ◽  
Shopping Malls ◽  
Economic Sectors ◽  
Long Distance ◽  
Vaccination Rates ◽  
Long Distance Transport ◽  
Health Situation ◽  
Distance Transport

Abstract Since August 9, the "health pass" became mandatory in France and applies to many economic sectors and social activities such as commercial catering, trade fairs and exhibitions, healthcare services and medical-social centres, public long-distance transport, and some stores and shopping malls. In addition, since September 30, 2021, the "health pass" has been made compulsory for minors aged 12 and two months to 17 years old. The aim is to better control the spread of the Sars-Cov-2 virus by forcing the entire population to be vaccinated in order to reduce the effects of the epidemic. Since vaccination is currently the only pursued strategy to fight against COVID-19 in the world, we were interested in verifying the explanation often put forward to justify the improvement (due to high vaccination rate) or the recrudescence (due to low vaccination percentage) of the health situation linked to COVID-19. At the same time, several developed countries have launched the injection of a third dose of vaccines following a substantial increase in COVID-19 cases. In this regard, we have studied the correlation between the levels of vaccination coverage (percentage of the vaccinated population) and the various epidemiological variables of COVID-19 in the 101 French departments (territories) during the month of September 2021. The findings of the study indicate no significant relationship between vaccination rates and COVID-19 data.

scholarly journals Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients Still Need to Be Prompted: A Systematic Review

Vaccines ◽  
2021 ◽  
Vol 9 (11) ◽  
pp. 1330
Author(s):  
Francesca Rosamilia ◽  
Giovanni Noberasco ◽  
Dario Olobardi ◽  
Andrea Orsi ◽  
Giancarlo Icardi ◽  
...  
Keyword(s):  
Systematic Review ◽  
Vaccine Coverage ◽  
Pneumococcal Vaccination ◽  
Vaccination Rate ◽  
Vaccination Rates ◽  
Increased Risk ◽  
Flu Vaccine ◽  
Vaccination Campaigns ◽  
Low Coverage ◽  
Current Guidelines

Systemic sclerosis (scleroderma, SSc) is an autoimmune connective tissue disease characterized by excessive production of collagen and multiorgan involvement. Scleroderma patients are at increased risk of influenza complications and pneumonia; thus, vaccinations are recommended. This systematic review evaluated the influenza and pneumococcus vaccination coverage for SSc patients. We included all studies from Pubmed reporting on influenza and pneumococcal vaccination rate in Scleroderma patients up to May 2021. The 14 studies thus selected identified a suboptimal vaccination rate in autoimmune and SSc patients, ranging from 28 to 59% for the flu vaccine, and from 11 to 58% for the pneumo vaccine in absence of specific vaccination campaigns, variously considering also other variables such as age, gender, vaccination settings, and possible vaccination campaigns. We also considered the reasons for low coverage and the approaches that might increase the vaccination rates. A lack of knowledge about the importance of vaccination in these patients and their doctors underlined the need to increase the awareness for vaccination in this patients’ category. Current guidelines recommend vaccination in elderly people and people affected by particular conditions that widely overlap with SSc, yet autoimmune diseases are not always clearly mentioned. Improving this suboptimal vaccination rate with clear guidelines is crucial for SSc patients and for clinicians to immunize these categories based principally on the pathology, prior to the age. Recommendations by the immunologist and the direct link to the vaccine providers can highly improve the vaccine coverage.

Sign in / Sign up

Export Citation Format

Share Document